Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis

Marion Bergmann1, Natasa Kukoc-Zivojnov, Kai U Chow

  • 1Department of Medicine III, Johann Wolfgang Goethe-University Hospital, Theodor-Stern-Kai-7, 60590, Frankfurt am Main, Germany.

Annals of Hematology
|August 19, 2004
PubMed

Insights

Prostate apoptosis response gene-4 (PAR-4) enhances CD95-induced apoptosis in lymphocytes by upregulating CD95 and downregulating FLIP. This promotes caspase activation and cell death, offering a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Prostate apoptosis response gene-4 (PAR-4) is implicated in apoptosis.
  • CD95 (Fas receptor) signaling mediates apoptosis in lymphocytes.
  • Dysregulation of apoptosis is a hallmark of neoplastic lymphocytes.

Purpose of the Study:

  • To investigate the functional role of PAR-4 in CD95-induced apoptosis of neoplastic lymphocytes.
  • To elucidate the molecular mechanisms by which PAR-4 influences CD95 signaling pathways.

Main Methods:

  • Overexpression of PAR-4 in Jurkat T-cell lines.
  • Analysis of CD95 receptor expression and FLICE-like inhibitory protein (FLIP) levels.
  • Assessment of initiator and executioner caspase activation (caspases-8, -10, -6, -7, -3).
  • Evaluation of mitochondrial pathway activation.
  • Inhibition of caspase-8 to study compensatory mechanisms.

Main Results:

  • PAR-4 overexpression upregulates cell surface CD95 receptor expression.
  • PAR-4 decreases FLIP levels, promoting cleavage of caspases-8 and -10.
  • Enforced activation of executioner caspases (-6, -7, -3) and mitochondrial pathway.
  • Inhibition of caspase-8 by PAR-4 leads to sustained apoptosis sensitivity via caspase-10 activation and downregulation of cIAP-2 and XIAP.

Conclusions:

  • PAR-4 significantly enhances CD95-induced apoptosis in neoplastic lymphocytes.
  • PAR-4 modulates key components of the extrinsic and intrinsic apoptosis pathways.
  • Targeting PAR-4 may represent a novel therapeutic strategy for lymphocyte malignancies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...